Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (481-490 of 610) with videos related to

Pageof 61
Sort By:
European Journal of Immunology|July 6, 2016
IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammationChia-Te Liao, Marcela Rosas, Luke C Davies, et al.
Blood|March 6, 2010
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemiaRonan T Swords, Kevin R Kelly, Peter G Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantationApostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, et al.
Cancer|December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaSusan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.
Journal of Cellular and Molecular Medicine|July 9, 2009
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulationJennifer S Carew, Ernest C Medina, Juan A Esquivel, et al.
Experimental Eye Research|December 18, 2008
A transcriptomic analysis of the EK1.Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescenceDavid Kipling, Dawn L Jones, S Kaye Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemiaGary J Schiller, Susan M O'Brien, Arnaud Pigneux, et al.
BMJ Open|April 11, 2023
Evaluating a co-designed care bundle to improve patient safety at discharge from adult and adolescent mental health services (SAFER-MH and SAFER-YMH): protocol for a non-randomised feasibility studyNatasha Tyler, Ioannis Angelakis, Richard Neil Keers, et al.
Blood|April 7, 2011
Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinibJorge E Cortes, Andreas Hochhaus, Philipp D le Coutre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Pageof 61

Showing results (481-490 of 610) with videos related to

Sort By:
Pageof 61
European Journal of Immunology|July 6, 2016
IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammationChia-Te Liao, Marcela Rosas, Luke C Davies, et al.
Blood|March 6, 2010
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemiaRonan T Swords, Kevin R Kelly, Peter G Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantationApostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, et al.
Cancer|December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaSusan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.
Journal of Cellular and Molecular Medicine|July 9, 2009
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulationJennifer S Carew, Ernest C Medina, Juan A Esquivel, et al.
Experimental Eye Research|December 18, 2008
A transcriptomic analysis of the EK1.Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescenceDavid Kipling, Dawn L Jones, S Kaye Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemiaGary J Schiller, Susan M O'Brien, Arnaud Pigneux, et al.
BMJ Open|April 11, 2023
Evaluating a co-designed care bundle to improve patient safety at discharge from adult and adolescent mental health services (SAFER-MH and SAFER-YMH): protocol for a non-randomised feasibility studyNatasha Tyler, Ioannis Angelakis, Richard Neil Keers, et al.
Blood|April 7, 2011
Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinibJorge E Cortes, Andreas Hochhaus, Philipp D le Coutre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Pageof 61